Differential contribution of bradykinin receptors in angiogenesis.
Morbidelli
L
L
Department of Pharmacology, University of Florence, Italy.
Parenti
A
A
Donnini
S
S
Granger
H J
HJ
Ledda
F
F
Ziche
M
M
D001920:Bradykinin / Q000378:metabolism / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement; D002478:Cells, Cultured; D003331:Coronary Vessels / Q000166:cytology; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000819:agonists / Q000378:metabolism*; D010738:Type C Phospholipases / Q000378:metabolism; D014699:Venules / Q000166:cytology
D065168:Bradykinin Receptor Antagonists; D016760:Proto-Oncogene Proteins c-fos; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D010738:Type C Phospholipases; D001920:Bradykinin